Laurence Sperling, MD: Population Health Approaches to Cardiovascular Disease Prevention

Despite historic public health efforts and landmark advances in pharmacotherapy during the last century, management and prevention of cardiovascular disease have persisted among the most pressing issues in public health.

In recent decades, public health has achieved notable victories, including reductions in smoking, that have contributed to a slowing in the rate of cardiovascular disease deaths, but a growing population, obesity epidemic, and rapid spread of misinformation in contemporary settings have kept prevention strategies at the forefront of conversations surrounding public health efforts.

The cardiology and medical community’s fight against cardiovascular disease attributable to lipid disorders was at the forefront of the Family Heart Foundation’s 2024 Family Heart Global Summit. During the meeting, which took place in Dallas, TX from September 22 to 24, 2024, leading providers and trialists in dyslipidemias brought forth data evidencing the progress and pitfalls of the medical community in this arena. During the 3-day meeting, which featured 6 sessions, attendees absorbed presentations on topics ranging from the impact of policy, historic trends in management for underserved populations, the future of lipoprotein(a) therapies, and more.

Following our preview interview, the editorial team of HCPLive Cardiology sat down with meeting cochair Laurence Sperling, MD, the Katz Professor in Preventive Cardiology and founder of the Emory Center for Heart Disease Prevention, during our time on-site at the Family Heart Foundation’s annual meeting. During our latest interview, Sperling, who led a presentation titled "Population Health Approaches to Accelerate the Prevention of CVD: Moving from Action to Impact,”, discusses the most effective population health strategies, the role of individual providers in public health efforts, and how social determinants of health can influence the success of population-level prevention programs.

Sperling has no relevant disclosures to report.

References:

Sperling L. Population Health Approaches to Accelerate the Prevention of CVD: Moving from Action to Impact. Presented at 2024 Family Heart Global Summit. Dallas, TX. September 22-24, 2024.